首个CDK4/6 抑制剂新药——Palbociclib
康建磊，王彦明
Palbociclib: a first-in-class CDK4/CDK6 inhibitor for the treatment of hormone-receptor positive advanced breast cancer
KANG Jian-lei1, WANG Yan-ming
临床药物治疗杂志
.
2016, (4): 85
-88
.
DOI: 10.3969/j.issn.1672-3384.2016.04.018
